CLINICAL

EVIDENCE

ActiPatch® has been clinically proven through a series of clinical studies, of which more are ongoing, at leading medical institutions.1
The technology has been used for decades in hospitals and clinics and has received an overwhelming number of positive testimonials from consumers.1

EVALUATION OF ACTIPATCH® IN A LANDMARK 5000 CHRONIC PAIN PATIENT STUDY

HOW THE STUDY WORKED:
5000 patients suffering from various types of chronic muscle and joint pain despite using numerous pain medications and therapies were asked to trial ActiPatch® for 7 days and report back on its effects.2 A second survey was conducted 3 months later in those who continued using ActiPatch®.2
RESULTS:

ActiPatch® reduced pain by more than 50% in two-thirds of patients after the 7-day trial and relief was sustained for more than 3 months with regular use.2

No major adverse events were reported.2

EFFECTIVENESS OF PAIN RELIEF BY ACTIPATCH®2

CONCLUSION: 

ActiPatch® appears to provide a clinically meaningful reduction of chronic muscle and joint pain affecting different locations of the body caused by a variety of conditions.2 ActiPatch® offers a new alternative chronic pain therapy.2

EVALUATION OF ACTIPATCH® IN A 6-MONTH CHRONIC PAIN PATIENT STUDY

HOW THE STUDY WORKED:
240 patients suffering from various types of chronic muscle and joint pain despite using numerous pain medications and therapies were asked to trial ActiPatch® for 7 days and report back on the effects. A second survey was conducted 6 months later in those who continued using ActiPatch®.3
RESULTS:
ActiPatch® reduced pain by at least 50% in 73% of patients after the 7-day trial and this relief was sustained by 52% of patients who reported at least a 60% reduction in pain by the end of six months of treatment.3 No significant adverse side effects were reported over 6 months of use.3
THE BENEFITS OF ACTIPATCH®
EXTENDED BEYOND PAIN RELIEF

CONCLUSION: 

Regular use of ActiPatch® sustained pain relief for 6 months in over 85% of chronic pain patients, and substantially improved physical activity, sleep quality, and overall quality of life.3 A decreased consumption of pain medication, including prescription and opioid-based pain medications.3

EVALUATION OF ACTIPATCH® IN KNEE OSTEOARTHRITIS

HOW THE STUDY WORKED:
60 Patients with knee osteoarthritis and persistent pain despite using maximum tolerated doses of conventional pain medications were asked to trial ActiPatch® for 1 month.7
RESULTS:
ActiPatch® reduced pain intensity and improved physical functioning.7 Some patients were able to reduce their consumption of pain medications.7

CONCLUSION: 

ActiPatch® is effective for pain caused by osteoarthritis of the knee.7

EVALUATION OF ACTIPATCH® IN NECK OSTEOARTHRITIS

HOW THE STUDY WORKED:
200 Patients with neck pain from osteoarthritis were treated with either ActiPatch® or etoricoxib 60 mg/day (a non-steroidal anti-inflammatory agent) for 1 month.6
RESULTS:
ActiPatch® resulted in a greater reduction in neck pain and improvement in quality of life compared to etoricoxib.6 Patients in the ActiPatch® group used 50% less rescue pain medication. There were no adverse effects in the ActiPatch® group compared to 11 in the etoricoxib group.6

CONCLUSION: 

In patients with neck osteoarthritis, ActiPatch® showed better pain relief with no adverse effects compared to etoricoxib.6

EVALUATION OF ACTIPATCH® IN CHRONIC BACK PAIN

HOW THE STUDY WORKED:
1394 Patients with chronic back pain despite using pain medications were asked to trial ActiPatch® for 7 days and to report back on the effects.8
RESULTS:
ActiPatch® reduced chronic back pain by more than 50% in two-thirds of patients after the 7-day trial.8 Half of all patients were able to stop or decrease their consumption of pain medications.8 No significant adverse events were reported.8

CONCLUSION: 

ActiPatch® effectively reduces chronic back pain for most patients and reduces the use of pain medication.8

EVALUATION OF ACTIPATCH® IN PLANTAR FASCIITIS

HOW THE STUDY WORKED:
70 patients with plantar fasciitis (heel pain) were treated with ActiPatch® for 7 days or placebo.9
RESULTS:
After a 7-day trial, ActiPatch® reduced pain by 40% compared to a 7% reduction by placebo.9 Some patients were able to reduce their use of pain medication.9 No adverse effects were noted.9

CONCLUSION: 

ActiPatch® offers a simple, drug-free, non-invasive therapy to reduce the pain associated with plantar fasciitis.9